C. Avicenne and P. , Médecine Interne ? Unité VIH / O Bouchaud; Anatomo-pathologie / M Ziol

. Garipuy and . Ferro-collados, Anatomo-pathologie, J Selves Virologie / F Nicot

P. Neau, L. Morlat, S. Lacaze-buzy, and . Caldato, Anatomo-pathologie / P Bioulac-Sage

R. 1. Ortego, C. Huedo-medina, T. Llorca, and J. , Adherence to Highly Active Antiretroviral Therapy (HAART): A Meta-Analysis, AIDS and Behavior, vol.49, issue.8, pp.1381-96, 2011.
DOI : 10.1007/s10461-011-9942-x

E. Mills, J. Nachega, and D. Bangsberg, Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators, PLoS Medicine, vol.24, issue.11, p.438, 2006.
DOI : 10.1371/journal.pmed.0030438.t007

L. Lal, R. Grimes, J. Swint, and J. Risser, A retrospective study to determine the impact of medical- and lifestyle-based contraindications to a prescribed HAART regimen on clinical outcomes and adherence, Journal of Clinical Pharmacy and Therapeutics, vol.33, issue.5, pp.429-468, 2006.
DOI : 10.1046/j.1532-5415.2002.50253.x

C. Leaver, G. Bargh, J. Dunn, and S. Hwang, The Effects of Housing Status on Health-Related Outcomes in People living with HIV: A Systematic Review of the Literature, AIDS and Behavior, vol.34, issue.10, pp.85-100, 2007.
DOI : 10.1007/s10461-007-9246-3

A. Palepu, M. Tyndall, K. Chan, E. Wood, J. Montaner et al., Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes, Antivir Ther, vol.9, issue.5, pp.713-722, 2004.

P. Frick, K. Tapia, P. Grant, M. Novotny, and J. Kerzee, The Effect of a Multidisciplinary Program on HAART Adherence, AIDS Patient Care and STDs, vol.20, issue.7, pp.511-535, 2006.
DOI : 10.1089/apc.2006.20.511

K. Wells, J. Golding, and M. Burnam, Psychiatric disorder in a sample of the general population with and without chronic medical conditions, Am J Psychiatry, vol.145, issue.8, pp.976-81, 1988.

M. Orlando, M. Burnam, and R. Beckman, Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV cost and services utilization study, International Journal of Methods in Psychiatric Research, vol.28, issue.2, pp.75-82, 2002.
DOI : 10.1002/mpr.125

F. Starace, A. Ammassari, and M. Trotta, Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.31, pp.136-145, 2002.
DOI : 10.1097/00126334-200212153-00010

G. Treisman and A. Angelino, Interrelation between Psychiatric Disorders and the Prevention and Treatment of HIV Infection, Clinical Infectious Diseases, vol.45, issue.Supplement 4, pp.313-320, 2007.
DOI : 10.1086/522556

J. Markowitz, J. Kocsis, and B. Fishman, Treatment of Depressive Symptoms in Human Immunodeficiency Virus???Positive Patients, Archives of General Psychiatry, vol.55, issue.5, pp.452-459, 1998.
DOI : 10.1001/archpsyc.55.5.452

P. Braitstein, A. Justice, and D. Bangsberg, Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort, AIDS, vol.20, issue.3, pp.323-354, 2006.
DOI : 10.1097/01.aids.0000198091.70325.f4

J. Yoon, P. Crane, P. Ciechanowski, R. Harrington, M. Kitahata et al., Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients, AIDS Care, vol.288, issue.10, pp.1208-1226, 2011.
DOI : 10.1023/A:1015240103565

M. Carta, J. Angst, and M. Moro, Association of chronic hepatitis C with recurrent brief depression Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy): e38668. 16. G.Dore. Access to HCV treatment for people with HIV/HCV al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings al. The Fifth Edition of the Addiction Severity Index, International AIDS Conference, pp.303-321, 1992.

K. Bradley, A. Debenedetti, R. Volk, E. Williams, D. Frank et al., AUDIT-C as a Brief Screen for Alcohol Misuse in Primary Care, Alcoholism: Clinical and Experimental Research, vol.93, issue.1, pp.1208-1225, 2007.
DOI : 10.1001/archinte.159.16.1946

A. Justice, W. Holmes, and A. Gifford, Development and validation of a self-completed HIV symptom index, Journal of Clinical Epidemiology, vol.54, issue.12, pp.77-90, 2001.
DOI : 10.1016/S0895-4356(01)00449-8

R. Furher and F. Rouillon, La version française de l'échelle CES-D. Description and translation of the auto-evaluation [in French], Psychiatrie et Psychobiologie, vol.4, pp.163-169, 1989.

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-491, 1977.
DOI : 10.1177/014662167700100306

S. Duran, C. Solas, and B. Spire, ???Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy???? A comparison between patients??? self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study, AIDS, vol.15, issue.8, pp.1075-1082, 2001.
DOI : 10.1097/00002030-200105250-00024

V. Soriano, K. Sherman, and J. Rockstroh, Challenges and opportunities for hepatitis C drug development in HIV???hepatitis C virus-co-infected patients, AIDS, vol.25, issue.18, pp.2197-208, 2011.
DOI : 10.1097/QAD.0b013e32834bbb90

D. Strader, Coinfection with HIV and Hepatitis C Virus in Injection Drug Users and Minority Populations, Clinical Infectious Diseases, vol.41, issue.Supplement 1, pp.7-13, 2005.
DOI : 10.1086/429489

M. Stein, D. Herman, and D. Solomon, Adherence to treatment of depression in active injection drug users, Journal of Substance Abuse Treatment, vol.26, issue.2, pp.87-93, 2004.
DOI : 10.1016/S0740-5472(03)00160-0

M. Schaefer, L. Capuron, and A. Friebe, Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems, J Hepatol Am J Gastroenterol, vol.28, issue.1018, pp.1804-1814, 2006.

J. Gonzalez, A. Batchelder, C. Psaros, and S. Safren, Depression and HIV/AIDS Treatment Nonadherence: A Review and Meta-analysis, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.58, issue.2, pp.181-188, 2011.
DOI : 10.1097/QAI.0B013E31822D490A
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858003

L. Yun, M. Maravi, J. Kobayashi, P. Barton, and A. Davidson, Antidepressant Treatment Improves Adherence to Antiretroviral Therapy Among Depressed HIV-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.432-440, 2005.
DOI : 10.1097/01.qai.0000147524.19122.fd

L. Michel, V. Villes, and F. Dabis, Role of treatment for depressive symptoms in relieving the impact of fatigue in HIV-HCV co-infected patients: ANRS Co13 Hepavih Alcohol use and HIV pharmacotherapy, J Viral Hepat AIDS Res Hum Retroviruses, vol.32, issue.1811, pp.757-70, 2002.

J. Samet, N. Horton, S. Meli, K. Freedberg, and A. Palepu, Alcohol Consumption and Antiretroviral Adherence Among HIV-Infected Persons With Alcohol Problems, Alcoholism: Clinical & Experimental Research, vol.42, issue.4, pp.572-579, 2004.
DOI : 10.1046/j.1525-1497.2003.20525.x

J. Campbell, H. Hagan, and M. Latka, High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities, Drug and Alcohol Dependence, vol.81, issue.3, pp.259-65, 2006.
DOI : 10.1016/j.drugalcdep.2005.07.005

L. Leggio, A. Ferrulli, and A. Zambon, Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection, Addictive Behaviors, vol.37, issue.4, pp.561-565, 2012.
DOI : 10.1016/j.addbeh.2011.12.010

L. Drumright, H. Hagan, and D. Thomas, Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention, Journal of Hepatology, vol.55, issue.1, pp.45-52, 2011.
DOI : 10.1016/j.jhep.2010.10.028

T. Kerr, B. Marshall, and M. Milloy, Patterns of heroin and cocaine injection and plasma HIV-1 RNA suppression among a long-term cohort of injection drug users, Drug and Alcohol Dependence, vol.124, issue.1-2, pp.108-120, 2012.
DOI : 10.1016/j.drugalcdep.2011.12.019

T. Sharpe, L. Lee, A. Nakashima, L. Elam-evans, and P. Fleming, Crack Cocaine Use and Adherence to Antiretroviral Treatment Among HIV-Infected Black Women, Journal of Community Health, vol.29, issue.2, pp.117-144, 2004.
DOI : 10.1023/B:JOHE.0000016716.99847.9b

L. Dutra, G. Stathopoulou, S. Basden, T. Leyro, M. Powers et al., A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders, American Journal of Psychiatry, vol.165, issue.2, pp.179-87, 2008.
DOI : 10.1176/appi.ajp.2007.06111851

J. Grabowski, H. Rhoades, and A. Stotts, Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials Rush CR, Stoops WW. Agonist replacement therapy for cocaine dependence: a translational review, Neuropsychopharmacology Future Med Chem, vol.29, issue.42, pp.969-81, 2004.
DOI : 10.1038/sj.npp.1300392
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.529.7980

E. Dakwar, E. Nunes, and A. Bisaga, A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers Looby A, Earleywine M. Negative consequences associated with dependence in daily cannabis users: 3. 44. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms, Am J Addict Subst Abuse Treat Prev Policy Am J Psychiatry, vol.20, issue.15812, pp.441-447, 2001.

M. Carrieri, C. Leport, and C. Protopopescu, Factors Associated With Nonadherence to Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.41, issue.4, pp.477-85, 2006.
DOI : 10.1097/01.qai.0000186364.27587.0e

P. Sullivan and M. Dworkin, Prevalence and Correlates of Fatigue Among Persons with HIV Infection, Journal of Pain and Symptom Management, vol.25, issue.4, pp.329-362, 2003.
DOI : 10.1016/S0885-3924(02)00676-0

P. Nieuwkerk and F. Oort, Self-Reported Adherence to Antiretroviral Therapy for HIV-1 Infection and Virologic Treatment Response, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.445-453, 2005.
DOI : 10.1097/01.qai.0000147522.34369.12

E. Golub, M. Latka, and H. Hagan, Screening for Depressive Symptoms Among HCV-Infected Injection Drug Users: Examination of the Utility of the CES-D and the Beck Depression Inventory, Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.81, issue.2, pp.278-90, 2004.
DOI : 10.1093/jurban/jth114

R. Fuhrer, F. Rouillon, J. Lellouch, A. Reichenberg, J. Gorman et al., Diagnostic reliability among French psychiatrists using DSM-III criteria, Acta Psychiatrica Scandinavica, vol.4, issue.1, pp.12-18, 1986.
DOI : 10.2307/2529310

M. Laguno, J. Blanch, and J. Murillas, Depressive symptoms after initiation of interferon therapy in human immunodeficiency virus-infected patients with chronic hepatitis C, Antivir Ther, vol.9, issue.6, pp.905-914, 2004.

F. Marcellin, M. Preau, I. Ravaux, P. Dellamonica, B. Spire et al., Self-Reported Fatigue and Depressive Symptoms as Main Indicators of the Quality of Life (QOL) of Patients Living with HIV and Hepatitis C: Implications for Clinical Management and Future Research, HIV Clinical Trials, vol.17, issue.1, pp.320-327, 2007.
DOI : 10.1097/01.psy.0000124757.10167.b1